Enzon Pharmaceuticals, Inc. (ENZN)

OTCMKTS · Delayed Price · Currency is USD
0.0499
-0.0101 (-16.83%)
At close: Mar 9, 2026
-58.07%
Market Cap 4.45M
Revenue (ttm) n/a
Net Income (ttm) -5.53M
Shares Out 74.21M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 373,493
Average Volume 59,888
Open 0.0301
Previous Close 0.0600
Day's Range 0.0150 - 0.0502
52-Week Range 0.0300 - 0.1299
Beta 0.08
RSI 37.94
Earnings Date Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol ENZN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.